questionText: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of providing access to Enhertu on the NHS for cancer patients.
answerText: Decisions on whether new medicines should be routinely funded by the NHS in England are taken by the National Institute for Health and Care Excellence (NICE) on the basis of an evaluation of a treatment’s costs and benefits. NICE’s methods are internation...
heading: Trastuzumab Deruxtecan